Ferrante and Lacktman Quoted on Florida’s Cut of Telemedicine out of Medical Marijuana Law
June 15, 2017
mHealthIntelligence
Attorneys Nate Lacktman and TJ Ferrante were recently quoted in an mHealthIntelligence article, “Florida Cuts Telemedicine out of New Medical Marijuana Law,” covering, as they relate to the newly passed legislation, the requirements of telemedicine-based medical marijuana exams and the legal precautions for marijuana use, possession and production.
Lacktman and Ferrante explained, “even in states that allow telemedicine-based examinations for medical marijuana, providers should keep in mind that the examination for the condition for which medical marijuana is being recommended must be an appropriate prior examination and meet the standard of care.”
Lacktman continued by saying, “it is also important to note federal law still criminalizes the possession, use, and sale of marijuana. The new Florida law does not immunize violations of such federal law or any non-medical use, possession, or production of marijuana.”
Lacktman’s and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Lacktman and Ferrante explained, “even in states that allow telemedicine-based examinations for medical marijuana, providers should keep in mind that the examination for the condition for which medical marijuana is being recommended must be an appropriate prior examination and meet the standard of care.”
Lacktman continued by saying, “it is also important to note federal law still criminalizes the possession, use, and sale of marijuana. The new Florida law does not immunize violations of such federal law or any non-medical use, possession, or production of marijuana.”
Lacktman’s and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Related News
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
January 2, 2026
In the News
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”